Your browser doesn't support javascript.
loading
Influence of Age and Message Frame on COVID-19 Vaccination Willingness Early in the Pandemic.
Spalvins, Nikita C; Leon, Tarren; Bailey, Phoebe E.
Afiliación
  • Spalvins NC; Western Sydney University, Sydney, NSW, Australia.
  • Leon T; University of Technology Sydney, Broadway, NSW, Australia.
  • Bailey PE; University of Technology Sydney, Broadway, NSW, Australia.
J Appl Gerontol ; 43(6): 716-722, 2024 06.
Article en En | MEDLINE | ID: mdl-38247320
ABSTRACT

Objective:

This study examined whether age would moderate the association between a brief message frame intervention and COVID-19 vaccine willingness.

Methods:

Data were collected in Australia between 25 June and 5 July 2021. Participants (N = 187) aged 18-85 years had not yet received a dose of COVID-19 vaccine. After random assignment to a gain- or loss-framed message, participants reported COVID-19 vaccine willingness, general anti-vaccine attitudes, approach and avoidance motivation, and COVID-19 illness risk perception.

Results:

Message frame did not influence COVID-19 vaccine willingness. However, greater COVID-19 illness risk perception and older age increased the odds of Pfizer vaccine willingness, while lower avoidance motivation increased the odds of AstraZeneca vaccine willingness. Greater anti-vaccine ideology decreased the odds of willingness to receive either of the COVID-19 vaccines.

Conclusions:

A brief message frame intervention did not influence COVID-19 vaccine willingness across the adult lifespan.
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Vacunas contra la COVID-19 / SARS-CoV-2 / COVID-19 Límite: Adolescent / Adult / Aged / Aged80 / Female / Humans / Male / Middle aged País/Región como asunto: Oceania Idioma: En Revista: J Appl Gerontol Año: 2024 Tipo del documento: Article País de afiliación: Australia Pais de publicación: Estados Unidos

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Vacunas contra la COVID-19 / SARS-CoV-2 / COVID-19 Límite: Adolescent / Adult / Aged / Aged80 / Female / Humans / Male / Middle aged País/Región como asunto: Oceania Idioma: En Revista: J Appl Gerontol Año: 2024 Tipo del documento: Article País de afiliación: Australia Pais de publicación: Estados Unidos